Taken together, the results of our comprehensive meta-analysis have demonstrated that BCAR4 expression is strong associated with unfavorable OS outcome and aggressive clinical features including metastasis and progression, suggesting an independent prognostic value for BCAR4 in human cancers and providing some insights for further research. The gene discussed is BCAR4; the disease is cancer.